# Edeniq

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/edeniq

- Industry: Renewable Energy
- Headquarters: Visalia, US
- Website: www.edeniq.com
- Total disclosed funding: $86M
- Latest round: Series C (Nov 3, 2014)
- Investors on record: 14

## About

Edeniq, Inc. is a company that specializes in analytical chemistry, focusing on precise carbohydrate analysis in agricultural materials, particularly for the biofuels sector.Founded in 2008 in Visalia, US, Edeniq, Inc. provides analytical solutions for the biofuels industry, particularly ethanol producers. The company has engaged in 12 deals, with its latest funding round being a GROWTH round in June 2017, raising USD 5.000 mn from investors including Angeleno Group and Cyrus Capital Partners. The company has not undergone any notable changes in its business operations and does not operate as a subsidiary of any parent company.Edeniq, Inc. specializes in innovative analytical chemistry methods through its flagship product, Intellulose®, designed to accurately determine sugars and carbohydrates in grains and agricultural materials. The technology addresses the critical need for precise carbohydrate analysis in the biofuels industry, particularly for ethanol producers in North America. Edeniq provides reliable testing services that support customers engaged in D3 Renewable Identification Number (RIN) production, with a client base including various ethanol producers across the United States and Canada.In 2015, Edeniq reported a revenue of USD 20.00 mn and an EBITDA of USD 6.00 mn. The company operates on a B2B model, generating revenue through its analytical testing services, which are essential for ethanol producers to meet regulatory requirements. Clients engage in ongoing partnerships with Edeniq for its Intellulose® testing methodology, ensuring consistent compliance and quality assurance, which fosters a steady revenue stream.Edeniq plans to utilize the USD 5.000 mn raised in June 2017 to enhance its analytical services and expand its market presence. The company aims to introduce new products tailored for the biofuels sector, with specific timelines for release expected in the upcoming years. Additionally, Edeniq is strategizing to expand into new geographic markets beyond North America, though specific regions have not been disclosed at this time.

## Funding rounds

- Series C, Nov 3, 2014, $4.1M — Draper Fisher Jurvetson
- Series C, May 28, 2013, $6.3M — Draper Fisher Jurvetson, Kleiner Perkins
- Series C, May 9, 2012, $30M — Draper Fisher Jurvetson, Kleiner Perkins, Cyrus Capital Partners, Element Partners, ATEL Capital Group, The Westly Group, Angeleno Group, I2BF, Epsilyte Holdings LLC
- Series B, Apr 28, 2010, $12M — Draper Fisher Jurvetson, Cyrus Capital Partners, Element Partners, The Westly Group, Angeleno Group, Advanced Equities, Omninet Capital, Nimes Capital
- Series A, May 30, 2008, $33M — Draper Fisher Jurvetson, Kleiner Perkins, DAG Ventures, Northgate Capital, Element Partners, The Westly Group, Angeleno Group, Advanced Equities, Omninet Capital

## Investors

- Draper Fisher Jurvetson (https://capitalatlas.ai/funds/draper-fisher-jurvetson) — Series A, Series B, Series C
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series C
- DAG Ventures (https://capitalatlas.ai/funds/dag-ventures) — Series A
- Northgate Capital (https://capitalatlas.ai/funds/northgate-capital) — Series A
- Element Partners (https://capitalatlas.ai/funds/element-partners) — Series A, Series B, Series C
- The Westly Group (https://capitalatlas.ai/funds/the-westly-group) — Series A, Series B, Series C
- Angeleno Group (https://capitalatlas.ai/funds/angeleno-group) — Series A, Series B, Series C
- Advanced Equities (https://capitalatlas.ai/funds/advanced-equities) — Series A, Series B
- Omninet Capital — Series A, Series B
- Cyrus Capital Partners — Series B, Series C
- Nimes Capital (https://capitalatlas.ai/funds/nimes-capital) — Series B
- ATEL Capital Group (https://capitalatlas.ai/funds/atel-capital-group) — Series C
- I2BF (https://capitalatlas.ai/funds/i2bf) — Series C
- Epsilyte Holdings LLC — Series C